Companies: 10,795·Total market cap: $144.5T
Universal Health Services, Inc.

Universal Health Services, Inc.

UHSNYSEHealthcare● Active
$141.18
$-3.99(-2.75%)
Market Cap$8.8B
P/E Ratio
52W High$246.33
52W Low$140.76

Universal Health Services, Inc. (UHS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

uhs · stock forecast · 43 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 43 Wall Street analysts in the past 3 months

SellBuy

Hold

43 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
18
Hold
23
Sell
2
Strong Sell
0
Total: 43 · Buy rate: 41.9%

12-Month Price Target

High

$310

Consensus

$216

+48.8% upside

Low

$165

Median: $204 · Last Close: $145.17

The Universal Health Services, Inc. (UHS) analyst consensus is Hold, based on ratings from 43 Wall Street analysts over the past 3 months. The average 12-month UHS price target is $216.00, representing +48.8% upside from the current price of $145.17.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $216 (48.8%)

Consensus Target

$216.00

48.8% upside

High Target

$310

113.5%

Low Target

$165

13.7%

Current Price

$145.17

as of today

Based on analyst price targets, the UHS stock price prediction for the next 12 months ranges from $165 to $310. The consensus UHS price forecast of $216.00 implies 48.8% upside from the current price of $145.17.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$137.915.00%

1-day model range: $137.12–$138.7. Peak: $138.7 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$171+17.6%
2028$189+30.1%
2029$201+38.4%
2030$209+43.6%
2031+46.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%0%86%
2Buy
0Neutral
12Sell
RSI (14)17.8Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · UHS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$144.22BUY
MA 10$148.61SELL
MA 20$158.33SELL
MA 50$169.71SELL
MA 100$187.89SELL
MA 200$199.55SELL
Current $UHS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$145.43SELL
EMA 10$149.10SELL
EMA 20$155.58SELL
EMA 50$168.62SELL
EMA 100$181.39SELL
EMA 200$189.64SELL
Current $UHS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-04-30
Maintains
BuyBuy
Cantor Fitzgerald2026-04-29
Maintains
NeutralNeutral
TD Cowen2026-04-29
Maintains
BuyBuy
Guggenheim2026-04-29
Maintains
BuyBuy
Baird2026-04-29
Maintains
NeutralNeutral
RBC Capital2026-04-29
Maintains
Sector PerformSector Perform
Barclays2026-04-28
Maintains
OverweightOverweight
Wells Fargo2026-03-02
Maintains
Equal WeightEqual Weight
Cantor Fitzgerald2026-02-27
Maintains
NeutralNeutral
Barclays2026-02-26
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Universal Health Services, Inc. (UHS) stock. Of the recent 337 rating actions, 28 were upgrades and 32 were downgrades. 43 analysts currently cover UHS.

Analyst Recommendation Trends

Buy ratings14↑ +3
Hold ratings03↑ +3
Sell ratings00

UHS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$17.4B

↓ 10.5% YoY

Revenue Next Year

$18.5B

↑ 6.8% YoY

EPS This Year

$21.74

EPS Next Year

$23.45

↑ 7.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast UHS EPS of $21.74 for the current fiscal year, based on estimates from 8 analysts. The UHS revenue forecast is $17.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The UHS stock forecast is supported by two independent data sources: analyst consensus ratings from 43 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus UHS price target is $216.00 (+48.8% upside), with an analyst consensus of Hold.

The UHS short-term stock prediction for tomorrow is $137.91 (-5.00%). The UHS stock price prediction for 2027 estimates an average of $171. The UHS stock prediction for 2030 projects a range of $198–$219.

Universal Health Services, Inc. trades on NYSE under the ticker UHS. The UHS stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 42% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

UHS forecast · 8 questions

According to 43 Wall Street analysts, the average 12-month UHS price target is $216.00, with a high forecast of $310.00 and a low of $165.00. The median price target is shown in the chart above when available. This implies +48.8% potential upside from the current price of $145.17.

UHS price targetWhat is UHS price targetUHS analyst price targetUHS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.